Alglucosidase Alfa Temporary Access Program

Clinical trial NCT00520143 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT00520143
Sponsor: Genzyme, a Sanofi Company
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Glycogen Storage Disease Type II (GSD-II)Pompe Disease (Late-Onset)Acid Maltase Deficiency Disease Glycogenosis 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.